뉴 지 랩 파마 ( NewG Lab Pharma ) 
 Company Info Philosophy History 
 Field of business Organization Business Partner 
 KAT ? Mechanism 
 Papers Patents Real World Case Study 
 Anticancer Therapeutics Kofactor 1 Kofactor 2 
 Clinical Development Laboratory Collaborations 
 News Media Book Notice 
 NEWGLAB Products 
 NewG Lab Pharma Inc . ( NGLPI ) mission is to develop 
 a new chemotherapy that will extend the life of cancer patients 
 without compromising quality of life . 
 KOfactor 1 
 KOfactor 1 ™ 
 Supplements / Adjuvants / Neo - Adjuvants 
 Natural compounds have a role to play in a holistic , multi - targeted approach to restoring health . 
 Certain natural compounds have demonstrated the ability to target metabolic and signaling pathways within 
 cells with minimal risk and toxicity . Moreover , combinations of specific natural compounds have demonstrated 
 combinational - synergy , with each compound enhancing the effect of the other . The combination of the natural 
 compounds incorporated in KOfactor 1 is supported by proprietary experimental data from the labs of KoDiscovery 
 in addition to the existing scientific literature . KOfactor 1 has been demonstrated to work synergistically 
 by affecting a multitude of cellular mechanisms : 
 Enhance apoptosis ( cell death ) 
 Reduce energy substrates available to cancer cells without affecting healthy cells . 
 Restore chemosensitivity 
 Luteolin , a naturally occurring flavonoid , has a robust amount of experimental data both in vitro and in vivo revealing a variety of anti - cancer mechanisms . 1 , 2 , 3 , 4 Rutin , also a naturally occurring flavonoid , has strong evidence demonstrating its ability to enhance cancer cell death by upregulating the genes involved in apoptosis and those involved in arresting cell - cycle progression . 5 , 6 , 7 Epigallocatechin - 3 - gallate ( EGCG ) , a polyphenol naturally occurring in green tea , has been extensively studied for decades for its anti - cancer properties . 8 , 9 Proprietary internal data obtained from in vitro experiments by Young Ko , Ph . D . , and colleagues , at her KoDiscovery lab , have demonstrated a synergy in killing cancer cells when Luteolin , Rutin and EGCG are combined in a specific ratio . KoFactor 1 contains this proprietary ratio of luteolin , Rutin and ECGC aimed to maximize benefit . 
 About Young Ko , PhD and background on Developing New Products 
 In addition to developing novel pharmaceuticals , Dr . Ko over the course of her scientific career has retained a passion for researching the latent potential within natural products to influence cellular physiology in a therapeutic manner . 
 “ The fields of Nutrition and Metabolism are my passion . I ’ ve always been fascinated by how what we eat influences our body , specifically , believing that certain natural compounds in plants are medicine . This is why animals instinctually know to eat herbs when they are sick . The compounds in herbs influence our epigenetics and metabolites in a specific way . Knowing the details of how each specific compound interacts with our bodies is critical . That ’ s why we only recommend certain natural compounds for certain conditions and for a certain amount of time . ” ~ Dr . Young Ko 
 Inspired from decades of passionate research , through a collaborative effort between NewG Lab Pharma and Dr . Young Ko , we are pleased to announce the creation of the KOfactor supplement line . Each KOfactor product consists of a novel combination of natural products selected to target specific cellular processes with mechanistic cohesion . Also , each KOfactor product is inspired by nature and guided by careful research that reveals the incredible potency of nature ’ s own pharmacy . 
 NEWGLAB PHARMA , INC . 
 701 E . Pratt Street , Baltimore , MD 21202 
 contact @ newglabpharma . com 
 NEWGLAB PHARMA KOREA Co . , Ltd . 
 13 F , 479 , Bongeunsa - ro , Gangnam - gu , Seoul , Korea ( 06095 ) 
 Copyright © 2019 NewG Lab Pharma , Inc . All Rights Reserved . 
 NEWGLAB PHARMA INC . 
 ADDRESS : 701 E Pratt St . Baltimore , 
 OFFICE : (+ 1 ) 443 - 887 - 4080 
 LAB : (+ 1 ) 443 - 887 - 4081 
 FAX : (+ 1 ) 410 - 234 - 8896